Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

COMy Virtual 2020 | Immunotherapy & myeloma: next steps

Hermann Einsele • 22 May 2020
COMy Virtual 2020
Multiple Myeloma CAR-T

Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany, discusses the strategies needed to improve the treatment of patients with multiple myeloma (MM). Prof. Einsele mentions resistance mechanisms, antigen loss and optimal treatment. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Hermann Einsele

Improving CAR-T in myeloma: dual-targeting approaches and resistance to T-cell exhaustion
1:35
Improving CAR-T in myeloma: dual-targeting approaches and resistance to T-cell exhaustion
Hermann Einsele • 17 Sep 2025
Ongoing trials in CAR T-cell therapy for multiple myeloma: the CARTITUDE trials and aMMbition
3:17
Ongoing trials in CAR T-cell therapy for multiple myeloma: the CARTITUDE trials and aMMbition
Hermann Einsele • 17 Sep 2025
CAR-T in multiple myeloma: optimizing bridging therapy & moving CAR-T into earlier lines of therapy
11:27
CAR-T in multiple myeloma: optimizing bridging therapy & moving CAR-T into earlier lines of therapy
Hermann Einsele • 10 Feb 2025
Novel CAR-T constructs on the horizon for multiple myeloma
1:16
Novel CAR-T constructs on the horizon for multiple myeloma
Hermann Einsele • 10 Feb 2025

Related Videos

A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Hermann Einsele • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Hermann Einsele • 15 Dec 2025
Motixafortide + G-CSF HSC mobilization in pts with myeloma following quadruplet induction therapy
1:40
Motixafortide + G-CSF HSC mobilization in pts with myeloma following quadruplet induction therapy
Hermann Einsele • 6 Dec 2025
WGS of cfDNA for assessment of MRD in high-risk smoldering multiple myeloma
2:13
WGS of cfDNA for assessment of MRD in high-risk smoldering multiple myeloma
Hermann Einsele • 8 Dec 2025
The content of VJHemOnc is intended for healthcare professionals